EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Survival outcomes for palliative pembrolizumab in head and neck cancer patients: real-world data from the north of England

Mohammed AlHilali, Rahul Patil, Malcolm Jackson, Josef Kovarik, Shahid Iqbal, Charles Kelly

The Royal College of Radiologists Open · 2023

DOI: 10.1016/j.rcro.2023.100009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Royal College of Radiologists Open, 2023. Verfasst von Mohammed AlHilali und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

AlHilali, M., Patil, R., Jackson, M., Kovarik, J., Iqbal, S., & Kelly, C. (2023). Survival outcomes for palliative pembrolizumab in head and neck cancer patients: real-world data from the north of England. The Royal College of Radiologists Open. https://doi.org/10.1016/j.rcro.2023.100009

Vancouver

AlHilali M, Patil R, Jackson M, Kovarik J, Iqbal S, Kelly C. Survival outcomes for palliative pembrolizumab in head and neck cancer patients: real-world data from the north of England. The Royal College of Radiologists Open. 2023. doi:10.1016/j.rcro.2023.100009

BibTeX
@article{AlHilali2023,
  author = {AlHilali, Mohammed and Patil, Rahul and Jackson, Malcolm and Kovarik, Josef and Iqbal, Shahid and Kelly, Charles},
  title = {Survival outcomes for palliative pembrolizumab in head and neck cancer patients: real-world data from the north of England},
  journal = {The Royal College of Radiologists Open},
  year = {2023},
  doi = {10.1016/j.rcro.2023.100009}
}
Kostenlos starten →